PER®Spectives: Advancing Treatment in nAMD and DME with Novel Therapies
Season 2, Episode 15, Feb 01, 09:59 PM
This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use of these agents — and corticosteroid implants for patients with DME — in the clinical setting.
Faculty:
Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research and Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada, Reno School of Medicine
Reno, NV
Ferhina Ali, MD, MPH
Assistant Professor, Vitreoretinal Surgery
Vitreoretinal Surgery Consultant and Fellowship Advisor
Clinical Research Investigator and Vitreoretinal Specialist
Consultant Medical Director
Clinical Instructor
Westchester Medical Center Health Network
Hawthorne, NY
Michael A. Singer, MD
Clinical Associate Professor
University of Texas Health Science Center
Medical Center Ophthalmology Associates, Director of Clinical Research
San Antonio, TX
Faculty:
Arshad M. Khanani, MD, MA, FASRS
Managing Partner
Director of Clinical Research and Director of Fellowship
Sierra Eye Associates
Clinical Associate Professor
University of Nevada, Reno School of Medicine
Reno, NV
Ferhina Ali, MD, MPH
Assistant Professor, Vitreoretinal Surgery
Vitreoretinal Surgery Consultant and Fellowship Advisor
Clinical Research Investigator and Vitreoretinal Specialist
Consultant Medical Director
Clinical Instructor
Westchester Medical Center Health Network
Hawthorne, NY
Michael A. Singer, MD
Clinical Associate Professor
University of Texas Health Science Center
Medical Center Ophthalmology Associates, Director of Clinical Research
San Antonio, TX